Results 171 to 180 of about 262,466 (282)
Identifying delayed human response to external risks: an econometric analysis of mobility change during a pandemic. [PDF]
Zhang G +4 more
europepmc +1 more source
Microstructure Evolution of a VMnFeCoNi High‐Entropy Alloy After Synthesis, Swaging, and Annealing
The synthesis and processing (rotary swaging and annealing) of the novel VMnFeCoNi alloy is investigated, alongside the estimation of the grain size effect on hardness. Analysis of a wide grain size range of recrystallized microstructures (12–210 µm) reveals a low annealing twin density.
Aditya Srinivasan Tirunilai +6 more
wiley +1 more source
Functional differential equations with infinite delays
openaire +2 more sources
Viktoriia Shtefan, Thorgund Nemec, Ute Hempel, Annett Gebert and coworkers demonstrate that anodic treatment of Ti–Cu‐based metallic glass in a nontoxic pyrophosphate electrolyte forms a protective bilayered Ti/Zr‐oxide film enriched with Cu nanocrystals.
Viktoriia Shtefan +8 more
wiley +1 more source
Myco-surface model for Fusarium solani growth and non-thermal plasma decontamination on building materials. [PDF]
Lokajová E +7 more
europepmc +1 more source
An Experimental High‐Throughput Approach for the Screening of Hard Magnet Materials
An entire workflow for the high‐throughput characterization and analysis of compositionally graded magnetic films is presented. Characterization protocols, data management tools and data analysis approaches are illustrated with test case Sm(Fe, V)12 based films.
William Rigaut +16 more
wiley +1 more source
Filamentation-assisted isolated attosecond pulse generation. [PDF]
Chien YE +8 more
europepmc +1 more source
This study presents novel anti‐counterfeiting tags with multilevel security features that utilize additional disguise features. They combine luminescent nanosized Ln‐MOFs with conductive polymers to multifunctional mixed‐matrix membranes and powder composites. The materials exhibit visible/NIR emission and matrix‐based conductivity even as black bodies.
Moritz Maxeiner +9 more
wiley +1 more source
On quality standards and the timing of pharmaceutical investment. [PDF]
Wei W.
europepmc +1 more source

